Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 108.64%1.8B | 98.51%1.03B | 100.58%493.22M | 6.37%1.2B | -1.76%863.81M | -8.37%518.48M | -22.34%245.9M | -10.45%1.13B | -7.77%879.32M | -14.72%565.83M |
| Refunds of taxes and levies | -36.43%25.23M | -31.69%17.53M | 1,486,290.97%10.07M | 405.02%42.28M | 374.02%39.69M | 206.53%25.67M | -99.99%677.48 | -66.26%8.37M | -55.81%8.37M | -28.01%8.37M |
| Cash received relating to other operating activities | 23.77%182.64M | -5.39%133.8M | 7.19%122.32M | -37.80%169.04M | -37.03%147.56M | -29.73%141.42M | -35.64%114.12M | 43.42%271.77M | 65.80%234.33M | 197.03%201.25M |
| Cash inflows from operating activities | 91.25%2.01B | 72.20%1.18B | 73.77%625.62M | 0.22%1.41B | -6.33%1.05B | -11.59%685.57M | -27.83%360.02M | -4.47%1.41B | 0.75%1.12B | 4.38%775.45M |
| Goods services cash paid | 73.50%1.15B | 59.84%651.63M | 29.29%287.03M | -9.45%975.96M | -21.57%664.73M | -27.03%407.67M | -20.94%222.01M | -22.00%1.08B | -20.04%847.55M | -18.13%558.72M |
| Staff behalf paid | 70.33%607.72M | 72.30%385.83M | 105.71%220.17M | 24.07%514.1M | 16.16%356.79M | 9.19%223.93M | -5.76%107.03M | 37.35%414.36M | 33.09%307.15M | 32.49%205.07M |
| All taxes paid | 172.32%12.17M | 102.74%8.43M | 10.50%2.61M | 4.45%5.24M | -11.28%4.47M | 61.32%4.16M | 82.35%2.36M | 7.92%5.02M | 22.10%5.04M | -34.59%2.58M |
| Cash paid relating to other operating activities | 48.70%391.42M | 33.51%231.88M | 29.50%90.98M | 36.43%277.18M | 76.77%263.23M | 43.34%173.67M | 27.20%70.26M | -66.71%203.16M | -72.85%148.91M | -74.34%121.16M |
| Adjustment items of operating cash outflws | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from operating activities | 67.90%2.16B | 57.86%1.28B | 49.58%600.8M | 4.24%1.77B | -1.48%1.29B | -8.80%809.43M | -10.92%401.67M | -26.02%1.7B | -29.01%1.31B | -32.42%887.53M |
| Adjustment items of net operating cash flow | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash flows from operating activities | 35.11%-154.55M | 21.53%-97.2M | 159.59%24.82M | -23.68%-360.44M | -27.62%-238.16M | -10.52%-123.87M | -186.86%-41.65M | 64.61%-291.43M | 74.43%-186.62M | 80.35%-112.08M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --67M | --67M | ---- | ---- | ---- | ---- | ---- | --12.5M | --260M | ---- |
| Cash received from returns on investments | 250.85%4.92M | 648.00%4.15M | --18.99K | -53.71%1.64M | -62.65%1.4M | --554.79K | ---- | 5,348.15%3.54M | 5,675.04%3.75M | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -36.44%4.57K | -31.46%3.79K | 200.79%3.79K | -99.16%7.24K | --7.19K | --5.53K | --1.26K | -81.20%865K | ---- | ---- |
| Cash received relating to other investing activities | -58.78%138.7M | -68.90%30M | --22.65M | 102.49%526.48M | 4,848.22%336.48M | --96.48M | ---- | 12,900.00%260M | --6.8M | ---- |
| Cash inflows from investing activities | -37.67%210.62M | 4.24%101.15M | 1,799,678.69%22.68M | 90.72%528.12M | 24.89%337.89M | --97.04M | --1.26K | 4,054.70%276.91M | 410,452.01%270.55M | ---- |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -1.36%139.22M | 49.24%103.14M | 190.28%75.25M | 60.04%199.49M | 87.84%141.14M | 39.99%69.11M | 22.14%25.92M | 39.94%124.65M | 15.74%75.14M | 36.82%49.37M |
| Cash paid to acquire investments | 37.42%349.91M | 59.97%335.91M | -42.92%113.74M | 50.68%284.03M | -41.26%254.63M | -30.42%209.98M | 1,892.71%199.27M | 250.87%188.5M | 4,139.90%433.49M | 3,672.25%301.78M |
| Net cash paid to acquire subsidiaries and other business units | --362.82M | --53.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | -54.11%160.61M | -76.29%40.3M | --27.5M | 106.61%545M | 31,000.32%350M | 52,143.39%170M | ---- | --263.78M | --1.13M | --325.4K |
| Cash outflows from investing activities | 35.77%1.01B | 18.65%532.85M | -3.86%216.49M | 78.28%1.03B | 46.30%745.77M | 27.77%449.09M | 613.78%225.19M | 304.02%576.93M | 578.34%509.75M | 697.32%351.47M |
| Adjustment items of net investing cash flow | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash flows from investing activities | -96.61%-801.94M | -22.62%-431.69M | 13.93%-193.82M | -66.79%-500.4M | -70.52%-407.89M | -0.17%-352.05M | -613.77%-225.19M | -120.39%-300.02M | -218.59%-239.2M | -698.51%-351.47M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --172.25M | --90M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --145.1M | --90M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 80.71%1.35B | 54.98%797.11M | 105.76%534.95M | 11.62%971.23M | 11.58%746.58M | 101.62%514.32M | 419.99%259.99M | -20.28%870.1M | -33.19%669.1M | -62.35%255.1M |
| Cash received relating to other financing activities | 233.33%8M | --2M | ---- | -70.00%2.4M | 60.00%2.4M | ---- | ---- | --8M | --1.5M | --1.5M |
| Cash inflows from financing activities | 104.20%1.53B | 72.87%889.11M | 105.76%534.95M | 10.88%973.63M | 11.69%748.98M | 100.44%514.32M | 419.99%259.99M | -72.32%878.1M | -33.04%670.6M | -62.13%256.6M |
| Borrowing repayment | 67.72%816.58M | 65.25%653.06M | 243.51%532.42M | 14.51%678.24M | -17.31%486.86M | -13.11%395.19M | -63.43%154.99M | 164.77%592.3M | 238.98%588.8M | 559.23%454.8M |
| Dividend interest payment | 32.00%38.08M | 29.78%24.58M | 33.88%12.34M | 59.78%39.45M | 72.34%28.85M | 71.76%18.94M | 44.53%9.22M | 13.81%24.69M | 20.94%16.74M | 26.63%11.03M |
| Cash payments relating to other financing activities | 206.43%38.47M | 278.51%24.93M | -50.13%1.95M | -39.73%19.47M | -55.76%12.55M | -75.15%6.59M | -80.96%3.91M | 90.26%32.31M | 369.56%28.38M | 570.95%26.5M |
| Cash outflows from financing activities | 69.07%893.13M | 66.99%702.56M | 225.19%546.71M | 13.53%737.16M | -16.67%528.27M | -14.55%420.72M | -62.70%168.12M | 147.47%649.3M | 227.46%633.92M | 502.99%492.33M |
| Net cash flows from financing activities | 188.29%636.3M | 99.29%186.54M | -112.80%-11.76M | 3.35%236.47M | 501.71%220.72M | 139.71%93.6M | 122.93%91.87M | -92.14%228.8M | -95.46%36.68M | -139.56%-235.73M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 527.91%1.44M | 21.88%1.59M | 526.73%903.05K | 4,552.04%3.48M | -150.78%-336.46K | 690.77%1.3M | 629.74%144.09K | -98.38%74.76K | -89.40%662.62K | -94.44%164.68K |
| Net increase in cash and cash equivalents | 25.12%-318.74M | 10.57%-340.76M | -2.88%-179.86M | -71.25%-620.89M | -9.58%-425.67M | 45.50%-381.01M | 54.51%-174.83M | -118.55%-362.57M | -4,276.06%-388.47M | -4,384.58%-699.12M |
| Add:Begin period cash and cash equivalents | -34.59%1.17B | -34.59%1.17B | -34.59%1.17B | -16.80%1.8B | -16.80%1.8B | -16.80%1.8B | -16.80%1.8B | 964.26%2.16B | 964.26%2.16B | 964.26%2.16B |
| End period cash equivalent | -37.53%855.45M | -41.06%833.44M | -38.63%994.34M | -34.59%1.17B | -22.60%1.37B | -3.05%1.41B | -8.63%1.62B | -16.80%1.8B | 734.36%1.77B | 679.35%1.46B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.